Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by O. Balogh
Budget Impact Analysis of Biosimilar Infliximab for the Treatment of Crohn's Disease in Six Central Eastern European Countries
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Related publications
Budget Impact Analysis of Biosimilar Infliximab (CT-P13) for the Treatment of Rheumatoid Arthritis in Six Central and Eastern European Countries
European Journal of Health Economics
Health Policy
Economics
Econometrics
Finance
PMD13 Assessing the Budget Impact of Using ScanBag® in CT in Six European Countries
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
A Budget Impact Analysis of Adalimumab Biosimilar: The Italian Context
AboutOpen
Central and Eastern European Countries (Information)
The Journal of Political Theory, Political Philosophy and Sociology of Politics Politeia
Pcn69 - Budget Impact of Substituting Biosimilar Trastuzumab (Ct-P6) in Treating Gastric Cancer and Breast Cancer in 28 European Countries
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Php320 - Analysis of Hta Process on the Basis of Pharmacoeconomic Guidelines in Central Eastern European Countries
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Infliximab, Azathioprine, or Combination Therapy for Crohn's Disease
New England Journal of Medicine
Medicine
Developing Cultural Industries in Central and Eastern European Countries
Management of Sustainable Development
Efficacy of Infliximab Biosimilars in Patients With Crohn's Disease
The Lancet
Medicine